Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | “Oral Mucositis-Pipeline Insights, 2015”- A DelveInsight’s ReportDelveInsight, the leading market research and consulting company has added new report Oral Mucositis-Pipeline Insights, 2015 to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight.
By: DelveInsight Business Research · R&D activities and technologies used along with the pipeline molecules in development. · Information related to collaborations, in-licensing and out-licensing deals. · Stages of development of pipeline molecules. · Therapeutic assessments by molecule types, route of administration, monotherapy and combination products. DelveInsight report on Oral Mucositis gives comparative study of drugs under development. The report provides assessment of AG-013 pipeline drug by ActogeniX NV (Intrexon) which is in Phase II/III. In addition to this, the report imparts information on several other drugs as well among which 6 are in phase II, 3 in phase I, 3 in pre - clinical and 1 in discovery phase. The Oral Mucositis-Pipeline Insights, 2015Report envisages Pipeline Intelligence by identifying the key players along with their potential pipeline molecule. Therefore DelveInsight’ DelveInsight is offering the Report at a price of USD 1,250 as a single user license, USD 2,500 as a site license and USD 4,000 as a Global/Enterprise License. For more information on Pipeline Insight Reports, email at info@delveInsight.com Keywords DelveInsight, Indication Pipeline Insight report, collaborations, licensing, Oral Mucositis, Oral Mucositis-Pipeline Insights, Pipeline molecules Contact Us: DelveInsight Business Research New Delhi-110075, India Phone: +91-11-45689769, +91 9650213330 Website: http://delveinsight.com About Us DelveInsight is a leading Business Consulting and Market Research Firm. We help our clients to find answers relevant to their business, facilitating decision-making; End
|
|